

Author: Russell R.L. Siedlak S.L. Raina A.K. Bautista J.M. Smith M.A. Perry G.
Publisher: Elsevier
ISSN: 0003-9861
Source: Archives of Biochemistry and Biophysics, Vol.370, Iss.2, 1999-10, pp. : 236-239
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
We analyzed glucose-6-phosphate dehydrogenase, the rate-controlling enzyme of the pentose phosphate pathway and free sulfhydryls, to study redox balance in Alzheimer disease. Glucose-6-phosphate dehydrogenase plays a pivotal role in homeostatic redox control by providing reducing equivalents to glutathione, the major nonenzymatic cellular antioxidant. There is a multitude of evidence that marks oxidative stress proximally in the natural history of Alzheimer disease. Consistent with a role for glutathione in defense against increased reactive oxygen, we found an upregulation of glucose-6-phosphate dehydrogenase together with increased sulfhydryls in Alzheimer disease. These data indicate that reductive compensation may play an important role in combating oxidative stress in Alzheimer disease.
Related content


By Ho H.-y. Cheng M.-l. Lu F.-j. Chou Y.-h. Stern A. Liang C.-m. Chiu D.T.-y.
Free Radical Biology and Medicine, Vol. 29, Iss. 2, 2000-07 ,pp. :


By Riganti C. Aldieri E. Bergandi L. Fenoglio I. Costamagna C. Fubini B. Bosia A. Ghigo D.
Free Radical Biology and Medicine, Vol. 32, Iss. 9, 2002-05 ,pp. :






Oxidative Stress Hypothesis in Alzheimer's Disease
Free Radical Biology and Medicine, Vol. 23, Iss. 1, 1997-01 ,pp. :